Bathing in emollients not effective in childhood eczema
(Source: PharmacoEconomics and Outcomes News)
Source: PharmacoEconomics and Outcomes News - May 1, 2018 Category: Drugs & Pharmacology Source Type: news

Delabelling penicillin allergy after testing is safe and cost saving
(Source: PharmacoEconomics and Outcomes News)
Source: PharmacoEconomics and Outcomes News - May 1, 2018 Category: Drugs & Pharmacology Source Type: news

Screening for Lynch syndrome cost  effective in CRC
(Source: PharmacoEconomics and Outcomes News)
Source: PharmacoEconomics and Outcomes News - May 1, 2018 Category: Drugs & Pharmacology Source Type: news

Cost of hepatic encephalopathy and its reduction with rifaximin
(Source: PharmacoEconomics and Outcomes News)
Source: PharmacoEconomics and Outcomes News - May 1, 2018 Category: Drugs & Pharmacology Source Type: news

Nonadherence may not increase schizophrenia costs
(Source: PharmacoEconomics and Outcomes News)
Source: PharmacoEconomics and Outcomes News - May 1, 2018 Category: Drugs & Pharmacology Source Type: news

ICER reviews on asthma, opioid abuse, plaque psoriasis therapies
(Source: PharmacoEconomics and Outcomes News)
Source: PharmacoEconomics and Outcomes News - May 1, 2018 Category: Drugs & Pharmacology Source Type: news

Health costs highest for lung  cancer
(Source: PharmacoEconomics and Outcomes News)
Source: PharmacoEconomics and Outcomes News - May 1, 2018 Category: Drugs & Pharmacology Source Type: news

Implementation of dofetilide initiation protocol reduces cost
(Source: PharmacoEconomics and Outcomes News)
Source: PharmacoEconomics and Outcomes News - May 1, 2018 Category: Drugs & Pharmacology Source Type: news

Australian government grants $A10  million for medical projects
(Source: PharmacoEconomics and Outcomes News)
Source: PharmacoEconomics and Outcomes News - May 1, 2018 Category: Drugs & Pharmacology Source Type: news

TNFi treatment persistence provides cost offsets
(Source: PharmacoEconomics and Outcomes News)
Source: PharmacoEconomics and Outcomes News - May 1, 2018 Category: Drugs & Pharmacology Source Type: news

Endometrial cancer telephone follow-up, a good call
(Source: PharmacoEconomics and Outcomes News)
Source: PharmacoEconomics and Outcomes News - May 1, 2018 Category: Drugs & Pharmacology Source Type: news

Proposed FDA sodium targets for food would save costs
(Source: PharmacoEconomics and Outcomes News)
Source: PharmacoEconomics and Outcomes News - May 1, 2018 Category: Drugs & Pharmacology Source Type: news

Vertex urged to reduce cost of Orkambi in UK
(Source: PharmacoEconomics and Outcomes News)
Source: PharmacoEconomics and Outcomes News - May 1, 2018 Category: Drugs & Pharmacology Source Type: news

Hospital costs for paediatric heart transplantation decreasing
(Source: PharmacoEconomics and Outcomes News)
Source: PharmacoEconomics and Outcomes News - May 1, 2018 Category: Drugs & Pharmacology Source Type: news

Cost-saving strategy in alpha  1-antitrypsin deficiency
(Source: PharmacoEconomics and Outcomes News)
Source: PharmacoEconomics and Outcomes News - May 1, 2018 Category: Drugs & Pharmacology Source Type: news

Routine immunisation not fully funded in China
(Source: PharmacoEconomics and Outcomes News)
Source: PharmacoEconomics and Outcomes News - May 1, 2018 Category: Drugs & Pharmacology Source Type: news

Assessing burden of polypharmacy in cancer survivors
(Source: PharmacoEconomics and Outcomes News)
Source: PharmacoEconomics and Outcomes News - May 1, 2018 Category: Drugs & Pharmacology Source Type: news

NICE guidance on tamoxifen prescribing has slow uptake
(Source: PharmacoEconomics and Outcomes News)
Source: PharmacoEconomics and Outcomes News - May 1, 2018 Category: Drugs & Pharmacology Source Type: news

Growth in prescription drug prices predicted in US
(Source: PharmacoEconomics and Outcomes News)
Source: PharmacoEconomics and Outcomes News - May 1, 2018 Category: Drugs & Pharmacology Source Type: news

Trends in healthcare spending in 188 countries
(Source: PharmacoEconomics and Outcomes News)
Source: PharmacoEconomics and Outcomes News - May 1, 2018 Category: Drugs & Pharmacology Source Type: news

Government expenditure on DAAs uncertain in Australia
(Source: PharmacoEconomics and Outcomes News)
Source: PharmacoEconomics and Outcomes News - May 1, 2018 Category: Drugs & Pharmacology Source Type: news

Time to vote in the National Pharmacy Board elections
Voting for this year’s National Pharmacy Board elections is now open. We have received 14 nominations for four substantive vacancies. The candidates are: Claire Anderson, Catherine Armstrong, (Source: Royal Pharmaceutical Society News)
Source: Royal Pharmaceutical Society News - April 30, 2018 Category: Drugs & Pharmacology Source Type: news

Novartis Receives FDA Approval of Tafinlar + Mekinist for Adjuvant Treatment of BRAF V600-Mutant Melanoma
:Basel, April 30, 2018 - Novartis announced today that the US Food and Drug Administration (FDA) has approved Tafinlar ® (dabrafenib) in combination with Mekinist® (trametinib) for the adjuvant treatment of patients with melanoma with BRAF V600E or... (Source: Drugs.com - New Drug Approvals)
Source: Drugs.com - New Drug Approvals - April 30, 2018 Category: Drugs & Pharmacology Source Type: news

FDA to Conduct Priority Review of Cemiplimab as a Potential Treatment for Advanced Cutaneous Squamous Cell Carcinoma
PARIS and TARRYTOWN, N.Y., April 30, 2018 /PRNewswire/ -- The U.S. Food and Drug Administration (FDA) has accepted for priority review the Biologics License Application (BLA) for cemiplimab for the treatment of patients with metastatic cutaneous... (Source: Drugs.com - New Drug Applications)
Source: Drugs.com - New Drug Applications - April 30, 2018 Category: Drugs & Pharmacology Source Type: news

What Causes Flushing?
Discussion Flushing is usually thought of as a benign condition such as blushing, but can be quite irritating if it is frequent or persistent (i.e. menopausal hot flashes) or even pathologic (i.e. malignancy). “Flushing is a subjective and sensation of warmth that is accompanied by reddening of the skin anywhere on the body but favors the face, neck, and upper torso…. Flushing can be broadly divided into episodic or persistent. Episodic flashing is mediated by the release of endogenous vasoactive mediators or medications, while persistent flushing result in a fixed facial erythema with telangiectasias and cyan...
Source: PediatricEducation.org - April 30, 2018 Category: Pediatrics Authors: pediatriceducationmin Tags: Uncategorized Source Type: news

---
(Source: Royal Pharmaceutical Society News)
Source: Royal Pharmaceutical Society News - April 27, 2018 Category: Drugs & Pharmacology Source Type: news

NHS Improvement Patient Safety Alert: Resources to support the safe adoption of the revised National Early Warning Score (NEWS2)
NHS Improvement has issued a resource alert to support the safe adoption of the revised National Early Warning Score (NEWS2)... (Source: Royal Pharmaceutical Society News)
Source: Royal Pharmaceutical Society News - April 27, 2018 Category: Drugs & Pharmacology Source Type: news

A potential new weapon in the addiction battle: FDA-approved diabetes and obesity drugs
Cocaine and other drugs of abuse hijack the natural reward circuits in the brain. In part, that's why it's so hard to quit using these substances. Moreover, relapse rates hover between 40 and 60 percent, similar to rates for other chronic conditions like hypertension and Type 1 diabetes. University of Pennsylvania behavioral pharmacologist and neuroscientist Heath Schmidt studies how long-term exposure to drugs such as cocaine, nicotine, and prescription opioids affects the brain and how these changes promote relapse in someone who has kicked the habit. (Source: World Pharma News)
Source: World Pharma News - April 27, 2018 Category: Pharmaceuticals Tags: Featured Research Research and Development Source Type: news

Gustav Born obituary
Prominent pharmacologist whose pioneering work on how the body stops bleeding improved the detection of thrombosisIn 1945, Gustav Born, a young and recently qualified doctor serving with the Royal Army Medical Corps, was among the first allied staff to witness the medical aftermath of the atomic bomb blast in Hiroshima. Among the horrific injuries he encountered, one struck him particularly forcibly: the tendency of the survivors to suffer from severe bleeding disorders. This, he surmised, was attributable to a lack of blood platelets caused by radiation damage. It was evidently a decisive experience, for it set the course...
Source: Guardian Unlimited Science - April 26, 2018 Category: Science Authors: Rod Flower Tags: Medical research People in science Medicine University of Oxford King's College London University of Cambridge Source Type: news

Clinical Trial Imaging Endpoint Process Standards Guidance for Industry
Clinical/Medical (Source: FDA Center for Drug Evaluation and Research - What's New)
Source: FDA Center for Drug Evaluation and Research - What's New - April 26, 2018 Category: Drugs & Pharmacology Source Type: news

NHS Improvement Patient Safety Alert: Risk of death or severe harm from inadvertent intravenous administration of solid organ perfusion fluids
NHS Improvement has issued a Patient Safety Alert: Risk of death or severe harm from inadvertent intravenous administration of solid organ perfusion fluids (Source: Royal Pharmaceutical Society News)
Source: Royal Pharmaceutical Society News - April 26, 2018 Category: Drugs & Pharmacology Source Type: news

Prevacid NapraPAC (Lansoprazole) - updated on RxList
(Source: RxList - New and Updated Drug Monographs)
Source: RxList - New and Updated Drug Monographs - April 26, 2018 Category: Drugs & Pharmacology Source Type: news

Prevacid I.V. (Lansoprazole for Injection) - updated on RxList
(Source: RxList - New and Updated Drug Monographs)
Source: RxList - New and Updated Drug Monographs - April 26, 2018 Category: Drugs & Pharmacology Source Type: news

Perspective on the Clinical Meaningfulness of IBD Trials Perspective on the Clinical Meaningfulness of IBD Trials
A new survey provides insight into the views of physicians regarding the clinical relevance of the results of IBD trials.Alimentary Pharmacology & Therapeutics (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - April 26, 2018 Category: Consumer Health News Tags: Gastroenterology Journal Article Source Type: news

Stavudine Capsules (New - Discontinuation)
Drug Shortage (Source: FDA Drug Shortages)
Source: FDA Drug Shortages - April 25, 2018 Category: Drugs & Pharmacology Source Type: news

Magnesium Sulfate Injection (New - Currently in Shortage)
Drug Shortage (Source: FDA Drug Shortages)
Source: FDA Drug Shortages - April 25, 2018 Category: Drugs & Pharmacology Source Type: news

Lidocaine HCl Topical Jelly (New - Discontinuation)
Drug Shortage (Source: FDA Drug Shortages)
Source: FDA Drug Shortages - April 25, 2018 Category: Drugs & Pharmacology Source Type: news

Ethiodized Oil (Lipiodol) Injection (Updated - Currently in Shortage)
Drug Shortage (Source: FDA Drug Shortages)
Source: FDA Drug Shortages - April 25, 2018 Category: Drugs & Pharmacology Source Type: news

Kenalog-40 Injection (Triamcinolone Acetonide Injectable Suspension) - updated on RxList
(Source: RxList - New and Updated Drug Monographs)
Source: RxList - New and Updated Drug Monographs - April 25, 2018 Category: Drugs & Pharmacology Source Type: news

Prednisolone Oral Solution (Prednisolone Sodium Phosphate Oral Solution) - updated on RxList
(Source: RxList - New and Updated Drug Monographs)
Source: RxList - New and Updated Drug Monographs - April 25, 2018 Category: Drugs & Pharmacology Source Type: news

Crysvita (Burosumab-twza injection, for Subcutaneous Use) - new on RxList
(Source: RxList - New and Updated Drug Monographs)
Source: RxList - New and Updated Drug Monographs - April 25, 2018 Category: Drugs & Pharmacology Source Type: news

Tavalisse (Fostamatinib Disodium Hexahydrate Tablets, for Oral Use) - new on RxList
(Source: RxList - New and Updated Drug Monographs)
Source: RxList - New and Updated Drug Monographs - April 25, 2018 Category: Drugs & Pharmacology Source Type: news

Drug safety update: Valproate medicines contraindicated in women and girls of childbearing potential
The Medicines and Healthcare products Regulatory Agency (MHRA) has issued a drug safety update: Valproate medicines (Epilim ▼, Depakote▼): contraindicated in women and girls of childbearing potential u (Source: Royal Pharmaceutical Society News)
Source: Royal Pharmaceutical Society News - April 25, 2018 Category: Drugs & Pharmacology Source Type: news

AbbVie Submits Biologics License Application to U.S. FDA for Investigational Treatment Risankizumab for Moderate to Severe Plaque Psoriasis
NORTH CHICAGO, Ill., April 25, 2018 /PRNewswire/ -- AbbVie (NYSE: ABBV), a research-based global biopharmaceutical company, announced that it has submitted a Biologics License Application (BLA) to the U.S. Food and Drug Administration for... (Source: Drugs.com - New Drug Applications)
Source: Drugs.com - New Drug Applications - April 25, 2018 Category: Drugs & Pharmacology Source Type: news

FDA Approves Jynarque (tolvaptan) to Slow Kidney Function Decline in Rapidly Progressing Autosomal Dominant Polycystic Kidney Disease
April 24, 2018 -- TOKYO--(BUSINESS WIRE)--Otsuka Pharmaceutical Co., Ltd. (Otsuka) announces that the U.S. Food and Drug Administration (FDA) has approved Jynarque (tolvaptan) as the first drug treatment to slow kidney function decline in adults at... (Source: Drugs.com - New Drug Approvals)
Source: Drugs.com - New Drug Approvals - April 24, 2018 Category: Drugs & Pharmacology Source Type: news

FDA Drug Safety Communication: FDA warns of serious immune system reaction with seizure and mental health medicine lamotrigine (Lamictal)
The Food and Drug Administration (FDA) is warning that the medicine lamotrigine (Lamictal) for seizures and bipolar disorder can cause a rare but very serious reaction that excessively activates the body ’s infection-fighting immune system. (Source: FDA Center for Drug Evaluation and Research - What's New)
Source: FDA Center for Drug Evaluation and Research - What's New - April 24, 2018 Category: Drugs & Pharmacology Source Type: news

RPS welcomes MHRA measures on sodium valproate
The RPS welcomes new measuresannounced today by the MHRA to help prevent harm to women taking sodium valproate. These include: All women of childbearing age taking part in a pregnancy prevention p (Source: Royal Pharmaceutical Society News)
Source: Royal Pharmaceutical Society News - April 24, 2018 Category: Drugs & Pharmacology Source Type: news

PPI Use and Mortality in Those With Pyogenic Liver Abscess PPI Use and Mortality in Those With Pyogenic Liver Abscess
A new study examines the impact of PPI treatment on mortality among patients with pyogenic liver abscess.Alimentary Pharmacology & Therapeutics (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - April 24, 2018 Category: Consumer Health News Tags: Gastroenterology Journal Article Source Type: news

Once-Daily Trelegy Ellipta Gains Expanded Indication in the US for the Treatment of Patients with COPD
24 April 2018 -- GlaxoSmithKline plc (LSE/NYSE: GSK) and Innoviva, Inc. (NASDAQ: INVA) today announced that the US Food and Drug Administration (FDA) has approved an expanded indication for Trelegy Ellipta (fluticasone... (Source: Drugs.com - New Drug Approvals)
Source: Drugs.com - New Drug Approvals - April 24, 2018 Category: Drugs & Pharmacology Source Type: news

Nanomedicine: Drugs can be made 'smarter'
(University of Lincoln) A new method has been developed to make drugs 'smarter' using nanotechnology so pharmacologists can tailor their drugs to more accurately target an area on the body, such as a cancer tumour. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - April 23, 2018 Category: International Medicine & Public Health Source Type: news